<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0000554'>Uveitis</z:hpo> is one of the major features of <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">behcet's disease</z:e> with relapse and remission pattern </plain></SENT>
<SENT sid="1" pm="."><plain>Severe presentation can be resistant to the conventional treatment </plain></SENT>
<SENT sid="2" pm="."><plain>Steroid has been used in the treatment of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">behcet</z:e>'s <z:hpo ids='HP_0000554'>uveitis</z:hpo>, although it especially has its own ocular complications when used in large doses </plain></SENT>
<SENT sid="3" pm="."><plain>We describe to patients presented with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0000554'>uveitis</z:hpo> while on treatment, <z:hpo ids='HP_0000554'>uveitis</z:hpo> was controlled by adding anti-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF) and Infliximab </plain></SENT>
</text></document>